Whittier Trust’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
Whittier Trust's ARKG Position: Q1 2026 in Review
Whittier Trust sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2026, closing a stake of 55 shares — an estimated $1.73K sold.
Whittier Trust first reported a position in ARKG in Q1 2022 and held it in 6 quarters. The position peaked at $32K in Q1 2022. 219 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.
- Whittier Trust reported no remaining ARK Genomic Revolution ETF position as of Q1 2026 after selling out during the quarter.
- Whittier Trust sold 55 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $1.73K.
- Whittier Trust first reported a position in ARK Genomic Revolution ETF in Q1 2022 and held it in 6 quarters.
- Whittier Trust's ARK Genomic Revolution ETF position peaked at $32K in Q1 2022.
- 219 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.
Based on Whittier Trust's 13F filing for Q1 2026, filed 28 Apr 2026.